Compassionate Cancer Res Grp

Fountain Valley, California 92708

0 studies enrolling now · 1 studies all time

What they study most

Multiple Myeloma

Studies at this site

• Study of Safety of Elotuzumab Administered Over Approximately 60 Minutes in Combination With Lenalidomide and Dexamethasone for Newly Diagnosed or Relapsed/Refractory Multiple Myeloma Patients — Completed